Redhill Biophrma ADR (RDHL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 286 | 0 | 6,530 | 61,800 | 85,757 |
| Cost of Goods | N/A | N/A | 3,459 | 33,337 | 49,406 |
| Gross Profit | 286 | N/A | 3,071 | 28,463 | 36,351 |
| Operating Expenses | 8,228 | 6,475 | -9,102 | 71,644 | 117,892 |
| Operating Income | -7,942 | -6,475 | 12,632 | -42,844 | -81,135 |
| Interest Expense | 1,456 | 1,512 | 9,605 | 42,387 | 16,660 |
| Other Income | 1,318 | 8,347 | 20,889 | 13,562 | 51 |
| Pre-tax Income | -8,080 | 360 | 23,916 | -71,669 | -97,744 |
| Net Income Continuous | -8,080 | 360 | 23,916 | -71,669 | -97,744 |
| Net Income Discontinuous | 7,651 | -8,628 | N/A | N/A | N/A |
| Net Income | $-429 | $-8,268 | $23,916 | $-71,669 | $-97,744 |
| EPS Basic Total Ops | 0.00 | 0.00 | 100.00 | -1,200.00 | -2,100.00 |
| EPS Basic Continuous Ops | -2.56 | 0.29 | 92.30 | -1,162.93 | -2,100.79 |
| EPS Basic Discontinuous Ops | 2.42 | -7.00 | N/A | N/A | N/A |
| EPS Diluted Total Ops | 0.00 | 0.00 | 100.00 | -1,200.00 | -2,100.00 |
| EPS Diluted Continuous Ops | -2.56 | 0.29 | 92.30 | -1,162.93 | -2,100.79 |
| EPS Diluted Discontinuous Ops | 2.42 | -7.00 | N/A | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | -2.56 | -6.71 | 92.25 | -1,157.50 | -2,100.00 |
| EBITDA(a) | $-7,533 | $-5,856 | $14,622 | $-34,690 | $-62,986 |